HC Wainwright & Co. Reiterates Buy on Korro Bio, Maintains $100 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Mitchell Kapoor has reiterated a Buy rating for Korro Bio (NASDAQ:KRRO) and maintained a $100 price target.
September 17, 2024 | 10:57 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. has reiterated a Buy rating for Korro Bio, maintaining a $100 price target, indicating confidence in the company's future performance.
The reiteration of a Buy rating and maintenance of a $100 price target by a reputable analyst suggests positive sentiment and potential upside for Korro Bio's stock. This could lead to increased investor interest and a positive short-term impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100